MKI67 and breast carcinoma: The Luminal B breast cancers typically express higher levels of the proliferation marker, Ki67 (5), show increased metastasis to lymph nodes, and have a worse prognosis and a greater chance for local recurrence and survival than patients with Luminal A subtype (6).